Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →Tata Consumer Products reported a strong Q3 FY25 with consolidated revenue growth of 17% YoY to INR 4,444 crore, driven by broad-based volume growth of 7% in India Beverages and robust performance in Foods (31% total, 11% organic).
✓ Verified against BSE filing
Tata Consumer Products reported a strong Q3 FY25 with consolidated revenue growth of 17% YoY to INR 4,444 crore, driven by broad-based volume growth of 7% in India Beverages and robust performance in Foods (31% total, 11% organic). However, consolidated EBITDA was flat YoY due to significant margin pressure in the India Tea business, where input costs rose 25-30% while only 40% was passed through via pricing. Management expects Q3 to be the peak of margin pressure, with gradual easing as price hikes flow through and new tea crop arrives in Q1 FY26. International and non-branded businesses delivered strong margin expansion. The company is prioritizing long-term competitiveness in tea, focusing on volume growth and market share gains. Risks include sustained high tea/coffee prices, competitive intensity in RTD, and slower-than-expected ramp-up of Capital Foods and Organic India.
टाटा कंज्यूमर प्रोडक्ट्स ने Q3 FY25 में मजबूत प्रदर्शन किया। कंपनी की कुल आय 17% बढ़कर ₹4,444 करोड़ हो गई। भारत में पेय पदार्थों की बिक्री 7% बढ़ी और खाद्य कारोबार ने 31% वृद्धि दर्ज की। लेकिन चाय के कारोबार में लागत 25-30% बढ़ने से मुनाफा पिछले साल जितना ही रहा। कंपनी ने कीमतों में केवल 40% बढ़ोतरी की। प्रबंधन का कहना है कि Q3 में मुनाफे पर सबसे ज्यादा दबाव था, अगली तिमाही में नई चाय की फसल आने से राहत मिलेगी। अंतरराष्ट्रीय और गैर-ब्रांडेड कारोबार ने अच्छा मुनाफा दिखाया। कंपनी चाय में बाजार हिस्सेदारी बढ़ाने पर ध्यान दे रही है। जोखिमों में चाय-कॉफी की ऊंची कीमतें और नए उत्पादों की धीमी बिक्री शामिल है।
0 delivered, 0 close, 2 missed.
View Promises →Sustained high tea prices
View Risks →Full transcript text is available on this route.
Read Transcript →Volume growth in packaged beverages India, a multi-quarter high, driven by strong execution and competitive pricing.
Another quarter of 110 bps MAT share gain in salt, indicating strong market position despite price increases.
E-commerce now accounts for 15% of total revenue, surpassing modern trade (14%), driven by 59% growth.
Ready-to-drink business exited December with 39% volume growth after correcting competitiveness issues.
Management expects Q3 to be the peak of tea margin pressure, with gradual improvement as price hikes flow through and new crop arrives in Q1 FY26.
After stabilization, focus shifts to accelerating growth with innovation and expansion into food services and pharma channels, expecting a substantial jump in Q4.
Target for growth businesses (Sampann, Soulfull, etc.) to grow at 30% and contribute 30% of portfolio; currently at 27% contribution with 89% growth.
Piloted in 10 cities, pharma channel to expand to 40 cities next year, driving significant uplift for Organic India.
After re-indexing pricing on Tata Gluco+, management expects the ready-to-drink business to resume its normative growth trajectory by the end of the current quarter.
The company is on track to deliver innovation as a percentage of sales above 5% for the full year, with Q2 at 4.1%.
Staggered price increases have been actioned and more are planned to mitigate the 30% tea cost inflation, though full pass-through depends on competitive dynamics.
Management reiterated commitment to improving EBITDA margins year-on-year, supported by new acquisitions and operating leverage, though near-term tea cost volatility is a watch-out.
Tea input costs remain elevated with only 40% passed through; if prices don't ease or further hikes aren't taken, margins could remain under pressure for two more quarters.
Coffee prices at 50-year highs; management is cautious on inventory and notes potential demand destruction if prices persist.
Analyst raised concern about new entrants and pricing aggression; management acknowledged matching deeper retail margins, impacting revenue growth.
Analyst questioned volume growth in Salt and Sampann given urban slowdown; management noted urban growth is low single digits excluding modern trade and e-commerce.
Tea input costs are up ~30% YoY, but competitive intensity has limited price increases, pressuring India branded margins. Management indicated they will not sacrifice market share for profitability.
Record high coffee prices are causing demand stress in the non-branded solubles business, which could lead to lower profitability as inventory advantages fade.
Analyst raised concern about weak demand at Starbucks and across FMCG. Management acknowledged urban stress due to food inflation and delayed government spending, with same-store sales negative.
Tata Gluco+ lost competitiveness due to delayed price re-indexing versus peers and new entrants like Campa Cola, leading to a 30% premium to competitors. Corrective actions taken but recovery uncertain.
Mentioned in Q1 FY25, Q3 FY24, Q4 FY24
Management reiterated commitment to grow the growth businesses (including acquisitions) from 20% to 30% of the India portfolio, with these businesses growing at 30% CAGR.
Mentioned in Q1 FY24, Q2 FY24, Q4 FY24
Management disputes Nielsen data showing 7% industry growth, claiming they haven't lost share. If competitive data confirms loss, tea volumes could remain soft.
Mentioned in Q1 FY24, Q2 FY24, Q3 FY24
Management remains confident of delivering INR 900-1,000 crore for NourishCo in FY24, despite Q3 being seasonally weak.
Mentioned in Q2 FY24, Q2 FY25
The company is on track to deliver innovation as a percentage of sales above 5% for the full year, with Q2 at 4.1%.
Mentioned in Q3 FY24, Q4 FY24
Simultaneous integration of Capital Foods and Organic India within 100 days each could strain resources and execution.
Management expects Q3 to be the peak of tea margin pressure, with gradual improvement as price hikes flow through and new crop arrives in Q1 FY26.
Tea input costs remain elevated with only 40% passed through; if prices don't ease or further hikes aren't taken, margins could remain under pressu...
View Risks →